Risk Analysis of Secondary Epilepsy in Patients with Acute Cerebrovascular Accident

April 28, 2025
92
УДК:  616.831-005.1:616.853-07
Resume

The development of secondary epilepsy is associated with an increased risk of mortality, deterioration of the general condition of patients and prolonged hospitalisation. The main risk factors for post-stroke epilepsy are acute symptomatic seizures, cortical lesions, stroke severity (more than 8 points on the NIHSS scale), stroke aetiology and patient age. Comorbidities, such as atrial fibrillation, diabetes mellitus, hypertension, and dyslipidaemia, also play an important role, although this relationship needs further study. Promising areas of research include the identification of biomarkers that can help predict the risk of developing post-stroke epilepsy and provide an individualised approach to prevention. Particular attention is drawn to circulating microRNAs that play a key role in the regulation of synaptic plasticity and neuroinflammatory processes, as well as electroencephalographic and neuroimaging markers. Studies of serological biomarkers, such as endostatin, S100B and Hsp70 proteins, and neural cell adhesion molecule (NCAM), show promise in predicting the risk of developing paroxysms. Further research in this area may contribute to the development of new therapeutic strategies and the improvement of models for predicting the risk of post-stroke epilepsy in patients after acute cerebrovascular accidents.

Cписок використаної літератури

  • 1. Ячнік О. (2020) Рекомендації щодо терапії постінсультної епілепсії. Інсульт, 1(52). health-ua.com/article/46177-rekomendatc-shodoterap-postnsultno-epleps.
  • 2. Sen A., Jette N., Husain M., Sander J.W. (2020) Epilepsy in older people. Lancet, 395: 10225: 735–748. doi.org/10.1016/S0140-6736(19)33064-8.
  • 3. Tanaka T. et al. (2024) Pathophysiology, diagnosis, prognosis, and prevention of poststroke epilepsy. Neurology, 102(11). doi.org/10.1212/wnl.0000000000209450.
  • 4. Коробка О. (2024) Сучасні аспекти діагностування та лікування постінсультної епілепсії. Інсульт, 1. health-ua.com/neurology/insult/76604-suchasn-aspekti-dagnostuvannya-talkuvannya-postnsultno-epleps.
  • 5. Ferreira‐Atuesta C., Döhler N., Erdélyi‐Canavese B. et al. (2021) Seizures after ischemic stroke: a matched multicenter study. Annals of Neurology. doi.org/10.1002/ana.26212.
  • 6. Punia V. (2022) Go ahead! Use that reperfusion treatment, don’t worry about subsequent seizures! Epilepsy Currents, 22(2): 105–107. doi.org/10.1177/15357597221076227.
  • 7. Ferreira-Atuesta C., Döhler N., Erdélyi-Canavese B. et al. (2021) Seizures after ischemic stroke: a matched multicenter study. Annals of Neurology, 90(5): 808–820. doi.org/10.1002/ana.26212.
  • 8. Tsoma Y., Studeniak T., Smolanka V. et al. (2021) Onset seizure as an isolated predictor of poor outcome after aneurysmal spontaneous subarachnoid hemorrhage. Int. Neurol. J., 4(98): 47–54. doi.org/10.22141/2224-0713.4.98.2018.139425.
  • 9. Mauritz M., Hirsch L.J., Camfield P. et al. (2022) Acute symptomatic seizures: an educational, evidence-based review. Epileptic Disorders, 24(1): 26–49. doi.org/10.1684/epd.2021.1376.
  • 10. Galovic M., Ferreira-Atuesta C., Abraira L. et al. (2021) Seizures and epilepsy after stroke: epidemiology, biomarkers and management. Drugs & Aging, 38(4): 285–299. doi.org/10.1007/s40266-021-00837-7.
  • 11. Pavlenko L., Striliuk O. (2024) Analysis of role stereotypes in interpersonal communication and their impact on gender equality. World Conference on Future Innovations and Sustainable Solutions. Futurity Research Publ. doi.org/10.5281/zenodo.14251765.
  • 12. Zöllner J.P., Misselwitz B., Kaps M. et al. (2020) National Institutes of Health Stroke Scale (NIHSS) on admission predicts acute symptomatic seizure risk in ischemic stroke: a population-based study involving 135,117 cases. Scientific Rep., 10(1): Article 3779. doi.org/10.1038/s41598-020-60628-9.
  • 13. Sinka L., Abraira L., Imbach L.L. et al. (2023) Association of mortality and risk of epilepsy with type of acute symptomatic seizure after ischemic stroke and an updated prognostic model. JAMA Neurol., 80(6): 605–613.
  • 14. Pitkänen A., Roivainen R., Lukasiuk K. (2016) Development of epilepsy after ischaemic stroke. Lancet Neurol., 15(2): 185–197.
  • 15. Šmigelskytė A., Gelžinienė G., Jurkevičienė G. (2023) Early epileptic seizures after ischemic stroke: their association with stroke risk factors and stroke characteristics. Medicina, 59(8): 1433. doi.org/10.3390/medicina59081433.
  • 16. Stefanidou M., Himali J.J., Devinsky O. et al. (2022) Vascular risk factors as predictors of epilepsy in older age: The Framingham Heart Study. Epilepsia, 63(1): 237–243.
  • 17. Gasparini S. et al. (2019) Hypertension, seizures, and epilepsy: a review on pathophysiology and management. Neurol. Sci., 40(9): 1775–1783.
  • 18. Schubert K.M., Schmick A., Stattmann M., Galovic M. (2025) Prognostic models for seizures and epilepsy after stroke, tumors and traumatic brain injury. Clin. Neurophysiol. Pract., 10: 116–128.
  • 19. Boot E.M. et al. (2023) Functional brain connectivity in young adults with post-stroke epilepsy. Brain Communications. doi.org/10.1093/braincomms/fcad277.
  • 20. Pryima M.Y., Studeniak T.O. (2024) Typical course of hippocampal sclerosis. Literature review. Int. Neurol. J., 20(4): 167–175.
  • 21. Morris G., Reschke C.R., Henshall D.C. (2019) Targeting microRNA-134 for seizure control and disease modification in epilepsy. EBioMedicine, 45: 646–654.
  • 22. Vangoor V.R. et al. (2019) Antagonizing increased miR-135a levels at the chronic stage of experimental TLE reduces spontaneous recurrent seizures. J. Neurosci., 39(26): 5064–5079. doi.org/10.1523/jneurosci.3014-18.2019.
  • 23. van Vliet E.A. et al. (2024) Circulating microRNAs and isomiRs as biomarkers for the initial insult and epileptogenesis in four experimental epilepsy models: The EPITARGET study. Epilepsia. doi.org/10.1111/epi.18134.
  • 24. Iwuchukwu I. et al. (2020) MicroRNA regulatory network as biomarkers of late seizure in patients with spontaneous intracerebral hemorrhage. Molecul. Neurobiol., 57(5): 2346–2357. doi.org/10.1007/s12035-020-01872-y.
  • 25. Yang H. et al. (2014) The ALDH2 rs671 polymorphism affects post-stroke epilepsy susceptibility and plasma 4-HNE levels. PLoS ONE, 9(10): e109634.
  • 26. Abraira L. et al. (2020) Correlation of blood biomarkers with early-onset seizures after an acute stroke event. Epilepsy & Behavior, 104: 106549.